What is Beroni Group Limited (BNIGF) stock price today?

Beroni Group Limited (BNIGF) is currently trading at $0.01, up 0% today.

What is BNIGF P/E ratio?

Beroni Group Limited's P/E ratio is -0.06. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is BNIGF return on equity (ROE)?

Beroni Group Limited's return on equity (ROE) is -76.18%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Beroni Group Limited's market cap?

Beroni Group Limited has a market capitalization of $212760.

OTC · Conglomerates

Beroni Group Limited (BNIGF) Stock

$0.01 +0.00% OTC: BNIGF Healthcare

Valuation

Metric	Value
Price	$0.01
Market Cap	$212760
P/E Ratio	-0.06
P/B Ratio	0.06
P/S Ratio	0.48
EPS (TTM)	$-0.13
52-Week High	$0.01
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-76.18%
ROA	-53.25%
ROCE	-186.17%
Gross Margin	75.17%
Operating Margin	-500.00%
Net Margin	-661.66%
Debt/Equity	0.36
Current Ratio	1.25

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.0M	$1.0M	$0	$0	$1.0M
Operating Profit	$-4.0M	$-9.0M	$-6.0M	$-12.0M	$-5.0M
Net Profit	$-3.0M	$-8.0M	$-9.0M	$-11.0M	$-4.0M
EPS	$-0.04	$-0.42	$-0.47	$-0.46	$-0.13
Op Margin	-168.6%	-1441.5%	-1200.1%	-3871.1%	-737.0%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$12.0M	$10.0M	$10.0M	$7.0M	$8.0M
Total Liabilities	$4.0M	$3.0M	$10.0M	$4.0M	$3.0M
Cash	$6.0M	$3.0M	$4.0M	$2.0M	$0
Borrowings	$3.0M	$2.0M	$5.0M	$2.0M	$2.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-2.0M	$-2.0M	$-3.0M	$-3.0M	$-2.0M
Investing Cash Flow	$0	$-2.0M	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$1.0M	$0
Net Cash Flow	$1.0M	$-3.0M	$1.0M	$-2.0M	$-1.0M
Free Cash Flow	$-2.0M	$-3.0M	$-3.0M	$-3.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.38
FCF Yield	-779.23%
Quick Ratio	1.24
Interest Coverage	—
Return 1Y	0.00%
Return 3Y	-99.94%
Return 5Y	—

Ownership

Insiders Held73.93%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CIRXCirtran Corp	$0.03	+0.00%	0.09	$148363	0.00%
CSLICritical Solutions, Inc.	$0.00	—	-1.00	$64860	0.00%
DLOCDigital Locations Inc	$0.00	—	-0.01	$73377	0.00%
DSUSDrone Services USA, Inc.	$0.00	—	-7.96	$65633	0.00%
ELGLElement Global, Inc.	$0.00	—	0.02	$81696	0.00%

About Beroni Group Limited

Beroni Group Limited, established in 2014 and based in Sydney, Australia, is a global enterprise operating in China, Australia, the United States, and Japan. The company specializes in the creation and distribution of a diverse portfolio of health and wellness products. Its offerings span several key areas: Smoking Harm Reduction: This includes products like NicoBloc, designed to aid in smoking cessation. Environmental Quality: Beroni provides air purification systems, such as Fogibloc, and water filtration solutions under the Olansi brand. Health and Wellness: The company supplies a variety of health supplements and also markets cosmetic products, including V show rejuvenation liquids and various hyaluronic acid and avocado-based intensive treatment masks. Stem cell-derived cosmetic products are also part of its range. Diagnostic Tools: Beroni is active in the diagnostics field, offering detection kits for viruses like the SARS-CoV-2 IgG/IgM antibody kit for COVID-19, as well as the CII-ArboViroPlex rRT-PCR assay, which identifies arboviruses such as Zika, Dengue, Chikungunya, and West Nile. Beyond product sales, Beroni Group is heavily invested in research and development. Its R&D efforts focus on discovering and developing novel pharmaceutical drugs, conducting clinical trials, and advancing anti-cancer therapies. The company also provides services in gene detection and diagnosis, infectious disease diagnostics, and offers cell therapies for both cancer treatment and anti-aging applications. Furthermore, Beroni manages an e-commerce platform dedicated to pharmaceutical and healthcare products.

Beroni Group Limited is headquartered in AU.

Beroni Group Limited (BNIGF) stock trades at $0.01 with a market capitalization of $212760. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.06, reflecting a net loss over the last twelve months, price-to-book of 0.06, price-to-sales of 0.48. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at or near its 52-week high.

On profitability, Beroni Group Limited generates a return on equity (ROE) of -76.18% (negative, reflecting a net loss), return on capital employed of -186.17%, an operating margin of -500.00%, a net profit margin of -661.66%.

Official website: www.beronigroup.com